These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 19812889

  • 1. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K.
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [Abstract] [Full Text] [Related]

  • 2. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
    Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM.
    J Rheumatol; 2004 Oct; 31(10):1955-8. PubMed ID: 15468359
    [Abstract] [Full Text] [Related]

  • 3. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA, Werth VP, Schumacher HR.
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.
    Guignard S, Gossec L, Bandinelli F, Dougados M.
    Clin Exp Rheumatol; 2008 Aug; 26(3 Suppl 49):S23-9. PubMed ID: 18799049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.
    Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P.
    J Rheumatol; 2003 Oct; 30(10):2287-91. PubMed ID: 14528531
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A, Kannangara S, Barnsley L.
    Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE.
    Scand J Rheumatol; 2007 Oct; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract] [Full Text] [Related]

  • 11. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA, Murray KJ.
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract] [Full Text] [Related]

  • 12. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.
    Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA.
    Scand J Rheumatol; 2009 Dec; 38(5):328-31. PubMed ID: 19579151
    [Abstract] [Full Text] [Related]

  • 13. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France.
    Saint Marcoux B, De Bandt M, CRI (Club Rhumatismes et Inflammation).
    Joint Bone Spine; 2006 Dec; 73(6):710-3. PubMed ID: 17127088
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.